Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Sihuan Pharma Sells 50% of Drug Distribution Subsidiary to Shandong Buchang

publication date: Jul 19, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Sihuan Pharmaceutical Holdings will sell a 50% stake in a drug distribution subsidiary to Shandong Buchang Pharmaceutical at a price of 637.5 million RMB ($98.6 million). Both companies have expertise in the cardio-cerebral vascular sector. It was a good deal for Sihuan, which purchased the assets last month for 775 million RMB ($120 million). More details....

Stock Symbol: (HK: 0640)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China


>>More events...
Our Partners
Annual Sponsors
 
Official Partners
 
Supporting Partners
 
Media Partners